Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 7;55(4):449-457.
doi: 10.1080/02786826.2020.1862409.

Efficacy of face masks, neck gaiters and face shields for reducing the expulsion of simulated cough-generated aerosols

Affiliations

Efficacy of face masks, neck gaiters and face shields for reducing the expulsion of simulated cough-generated aerosols

William G Lindsley et al. Aerosol Sci Technol. .

Abstract

Face masks are recommended to reduce community transmission of SARS-CoV-2. One of the primary benefits of face masks and other coverings is as source control devices to reduce the expulsion of respiratory aerosols during coughing, breathing, and speaking. Face shields and neck gaiters have been proposed as an alternative to face masks, but information about face shields and neck gaiters as source control devices is limited. We used a cough aerosol simulator with a pliable skin headform to propel small aerosol particles (0 to 7 μm) into different face coverings. An N95 respirator blocked 99% (standard deviation (SD) 0.3%) of the cough aerosol, a medical grade procedure mask blocked 59% (SD 6.9%), a 3-ply cotton cloth face mask blocked 51% (SD 7.7%), and a polyester neck gaiter blocked 47% (SD 7.5%) as a single layer and 60% (SD 7.2%) when folded into a double layer. In contrast, the face shield blocked 2% (SD 15.3%) of the cough aerosol. Our results suggest that face masks and neck gaiters are preferable to face shields as source control devices for cough aerosols.

Keywords: Airborne transmission; Face masks; Face shields; Infection control; Infectious disease transmission.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests Statement The authors declare no competing interests.

Figures

Figure 1:
Figure 1:
Cough aerosol simulator system for source control measurements. The system consists of an aerosol generation system, a bellows and linear motor to produce the simulated cough, a pliable skin head form on which the face mask, neck gaiter or face shield is placed, a 105 liter collection chamber into which the aerosol is coughed, and an Andersen impactor to separate the aerosol particles by size and collect them. More information about the cough aerosol simulator is provided in the supplemental online materials.
Figure 2:
Figure 2:
Mass of aerosol collected in each size fraction. The graph shows the amount of simulated respiratory aerosol that was collected from the collection chamber in each aerosol particle size fraction after a single simulated cough. The bars show the mean and standard deviation. A larger color version of this figure is shown in the supplemental online materials.
Figure 3:
Figure 3:
Collection efficiency of face masks, neck gaiter and face shield. The collection efficiency is the percentage of aerosol particles that were blocked by the face mask, neck gaiter or face shield compared with experiments without a device. The plot shows the means and standard deviations of the collection efficiency in each size fraction. A larger version of this figure is shown in color in the supplemental online materials.

References

    1. Anderson EL, Turnham P, Griffin JR, and Clarke CC 2020. Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal. 40:902–907. doi: 10.1111/risa.13500. - DOI - PMC - PubMed
    1. Asadi S, Cappa CD, Barreda S, Wexler AS, Bouvier NM, and Ristenpart WD 2020. Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities. Sci. Rep 10:15665. doi: 10.1038/s41598-020-72798-7. - DOI - PMC - PubMed
    1. Bahl P, Doolan C, de Silva C, Chughtai AA, Bourouiba L, and MacIntyre CR 2020. Airborne or droplet precautions for health workers treating COVID-19? J. Infect. Dis doi: 10.1093/infdis/jiaa189. - DOI - PMC - PubMed
    1. Bergman MS, Zhuang Z, Hanson D, Heimbuch BK, McDonald MJ, Palmiero AJ, Shaffer RE, Harnish D, Husband M, and Wander JD 2014. Development of an advanced respirator fit-test headform. J. Occup. Environ. Hyg 11:117–25. doi: 10.1080/15459624.2013.816434. - DOI - PMC - PubMed
    1. Bourouiba L, Dehandschoewercker E, and Bush John W. M. 2014. Violent expiratory events: on coughing and sneezing. J. Fluid Mech 745:537–563. doi: 10.1017/jfm.2014.88. - DOI